Shigella Diarrhoea Prophylaxis Market Report 2026
Download Free Sample Buy Now
Shigella Diarrhoea Prophylaxis Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Shigella Diarrhoea Prophylaxis Market Report 2026

Global Outlook – By Type (Vaccination, Antibiotic Prophylaxis, Public Health Measures, Hygiene Education), By Route of Administration (Oral, Parenteral, Other Administrations), By End User (Healthcare Facilities, Travel Clinics, Pharmacies, Government Health Programs) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Shigella Diarrhoea Prophylaxis Market Overview

• Shigella Diarrhoea Prophylaxis market size has reached to $2.12 billion in 2025

• Expected to grow to $3.11 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%

• Growth Driver: Increasing Hygiene And Sanitation Awareness Fueling The Growth Of The Market Due To Rising Efforts To Prevent Disease Transmission

• Market Trend: Advancements In Vaccine Technology Driving Progress In Shigella Diarrhoea Prevention

• North America was the largest region in 2025.

What Is Covered Under Shigella Diarrhoea Prophylaxis Market?

Shigella diarrhoea prophylaxis refers to the preventive measures taken to reduce the risk of infection caused by Shigella bacteria, which are responsible for causing acute diarrhoeal illness. This form of prophylaxis focuses on interrupting the transmission of the pathogen through improved sanitation, personal hygiene practices, safe handling and consumption of food and water, and public health interventions.

The main types of shigella diarrhoea prophylaxis include vaccination, antibiotic prophylaxis, public health measures, and hygiene education. Vaccination refers to the administration of a vaccine to stimulate an individual's immune system to recognize and fight specific pathogens. It can be administered through oral, parenteral, and other routes and is used by various end-users such as healthcare facilities, travel clinics, pharmacies, and government health programs.

Shigella Diarrhoea Prophylaxis Market Global Report 2026 Market Report bar graph

What Is The Shigella Diarrhoea Prophylaxis Market Size and Share 2026?

The shigella diarrhoea prophylaxis market size has grown strongly in recent years. It will grow from $2.12 billion in 2025 to $2.29 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to limited access to vaccines in developing regions, prevalence of shigella outbreaks, low awareness of hygiene practices, insufficient water and sanitation infrastructure, reliance on traditional antibiotic treatments.

What Is The Shigella Diarrhoea Prophylaxis Market Growth Forecast?

The shigella diarrhoea prophylaxis market size is expected to see strong growth in the next few years. It will grow to $3.11 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to development of new oral and injectable vaccines, expansion of global immunization programs, rising government initiatives for public health, adoption of advanced hygiene education programs, integration of digital surveillance and outbreak tracking systems. Major trends in the forecast period include increased adoption of oral and injectable vaccines, rising implementation of antibiotic prophylaxis programs, expansion of community health campaigns and public awareness initiatives, focus on water, sanitation, and waste management improvements, growing hygiene education and safe food handling practices.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Shigella Diarrhoea Prophylaxis Market Segmentation

1) By Type: Vaccination, Antibiotic Prophylaxis, Public Health Measures, Hygiene Education

2) By Route of Administration: Oral, Parenteral, Other Administrations

3) By End User: Healthcare Facilities, Travel Clinics, Pharmacies, Government Health Programs

Subsegments:

1) By Vaccination: Oral Vaccines, Injectable Vaccines, Combination Vaccines

2) By Antibiotic Prophylaxis: Ciprofloxacin, Azithromycin, Ceftriaxone, Ampicillin, Levofloxacin

3) By Public Health Measures: Water And Sanitation Improvements, Improved Waste Management, Community Health Campaigns

4) By Hygiene Education: Handwashing Campaigns, Safe Food Handling And Preparation Practices, Personal Hygiene Education, Public Awareness Programs

What Is The Driver Of The Shigella Diarrhoea Prophylaxis Market?

The increasing awareness of hygiene and sanitation is expected to propel the growth of the shigella diarrhoea prophylaxis market going forward. Hygiene and sanitation refer to the actions and environmental conditions that promote health and reduce disease transmission through cleanliness and proper waste management. The rise in hygiene and sanitation is driven by increasing awareness of health risks, with more people recognizing the importance of cleanliness in preventing the spread of infectious diseases. Awareness of hygiene and sanitation supports Shigella diarrhoea prophylaxis by reducing person-to-person transmission, as individuals who understand and practice proper handwashing and waste disposal significantly lower the risk of spreading the bacteria in communities. For instance, in March 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, 57% of the global population, or 4.6 billion people, had access to safely managed sanitation services. Among them, 33%, or 2.7 billion people, used private sanitation facilities connected to sewers where the wastewater was treated, while 21%, or 1.7 billion people, used toilets or latrines that safely disposed of waste on-site. Therefore, the increasing awareness of hygiene and sanitation will fuel the growth of the shigella diarrhoea prophylaxis industry.

Key Players In The Global Shigella Diarrhoea Prophylaxis Market

Major companies operating in the shigella diarrhoea prophylaxis market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Viatris Inc., Chongqing Zhifei Biological Products Co. Ltd., Macleods Pharmaceuticals Limited, Alkem Laboratories Limited, Alembic Pharmaceuticals Limited, Vaxcyte Inc., Valneva SE, Sanaria Inc., Intravacc B.V., LimmaTech Biologics AG, Intralytix Inc., Immuron Limited, Institut Pasteur, Hetero Drugs Limited, Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Company Limited, Janssen Pharmaceuticals (Johnson & Johnson), Sanofi Pasteur, Biological E Limited, Sinovac Biotech Ltd., Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL), Emergent BioSolutions Inc., Codagenix Inc., Indian Immunologicals Limited.

Global Shigella Diarrhoea Prophylaxis Market Trends and Insights

Major companies operating in the shigella diarrhoea prophylaxis market are focusing on developing advanced solutions, such as tetravalent bioconjugate shigellosis vaccines, to enhance immune response. Tetravalent bioconjugate shigellosis vaccines are advanced vaccines designed to protect against four major Shigella serotypes by linking bacterial polysaccharides to a carrier protein to enhance immune response. For instance, in November 2024, Valneva SE, a France-based biotech company, and LimmaTech Biologics AG, a Switzerland-based clinical-stage biotech firm, decleared the first participant has been vaccinated in a Phase 2 infant safety and immunogenicity study of Shigella4V2 (S4V2), which is currently the world’s most clinically advanced tetravalent bioconjugate vaccine candidate targeting shigellosis. This marks a significant milestone in the global effort to develop a vaccine against Shigella, a major cause of severe diarrheal disease in children. S4V2 will undergo testing for safety and preliminary efficacy in around 120 healthy adults aged 18 to 50 who have not previously been exposed to Shigella at three locations in the United States

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Shigella Diarrhoea Prophylaxis Market?

In August 2024, Valneva SE, a France-based specialty vaccine company, partnered with LimmaTech to accelerate the development of the advanced tetravalent shigella vaccine candidate. The partnership enables Valneva to advance a promising program addressing a critical unmet medical need. It also highlights LimmaTech’s expertise in vaccine development and their ability to rapidly accelerate program progress. LimmaTech is a Switzerland-based company developing a tetravalent shigella vaccine candidate.

Regional Insights

North America was the largest region in the shigella diarrhoea prophylaxis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Shigella Diarrhoea Prophylaxis Market?

The shigella diarrhoea prophylaxis market consists of revenues earned by entities by providing services such as water quality testing, educational campaigns, infection control consulting, and food safety services. The market value includes the value of related goods sold by the service provider or included within the service offering. The shigella diarrhoea prophylaxis market also includes sales of hand sanitizers, antibacterial soaps, disinfectants, and surface cleaner. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Shigella Diarrhoea Prophylaxis Market Report 2026?

The shigella diarrhoea prophylaxis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the shigella diarrhoea prophylaxis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Shigella Diarrhoea Prophylaxis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.29 billion
Revenue Forecast In 2035 $3.11 billion
Growth Rate CAGR of 8.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Route of Administration, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Viatris Inc., Chongqing Zhifei Biological Products Co. Ltd., Macleods Pharmaceuticals Limited, Alkem Laboratories Limited, Alembic Pharmaceuticals Limited, Vaxcyte Inc., Valneva SE, Sanaria Inc., Intrav
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Shigella Diarrhoea Prophylaxis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Shigella Diarrhoea Prophylaxis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Shigella Diarrhoea Prophylaxis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Shigella Diarrhoea Prophylaxis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increased Adoption Of Oral And Injectable Vaccines

4.2.2 Rising Implementation Of Antibiotic Prophylaxis Programs

4.2.3 Expansion Of Community Health Campaigns And Public Awareness Initiatives

4.2.4 Focus On Water, Sanitation, And Waste Management Improvements

4.2.5 Growing Hygiene Education And Safe Food Handling Practices

5. Shigella Diarrhoea Prophylaxis Market Analysis Of End Use Industries

5.1 Healthcare Facilities

5.2 Travel Clinics

5.3 Pharmacies

5.4 Government Health Programs

5.5 Non-Governmental Organizations (NGOs)

6. Shigella Diarrhoea Prophylaxis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Shigella Diarrhoea Prophylaxis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Shigella Diarrhoea Prophylaxis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Shigella Diarrhoea Prophylaxis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Shigella Diarrhoea Prophylaxis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Shigella Diarrhoea Prophylaxis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Shigella Diarrhoea Prophylaxis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Shigella Diarrhoea Prophylaxis Market Segmentation

9.1. Global Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vaccination, Antibiotic Prophylaxis, Public Health Measures, Hygiene Education

9.2. Global Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Administrations

9.3. Global Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Healthcare Facilities, Travel Clinics, Pharmacies, Government Health Programs

9.4. Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Vaccination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Vaccines, Injectable Vaccines, Combination Vaccines

9.5. Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Antibiotic Prophylaxis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ciprofloxacin, Azithromycin, Ceftriaxone, Ampicillin, Levofloxacin

9.6. Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Public Health Measures, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Water And Sanitation Improvements, Improved Waste Management, Community Health Campaigns

9.7. Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Hygiene Education, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Handwashing Campaigns, Safe Food Handling And Preparation Practices, Personal Hygiene Education, Public Awareness Programs

10. Shigella Diarrhoea Prophylaxis Market Regional And Country Analysis

10.1. Global Shigella Diarrhoea Prophylaxis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Shigella Diarrhoea Prophylaxis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Shigella Diarrhoea Prophylaxis Market

11.1. Asia-Pacific Shigella Diarrhoea Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Shigella Diarrhoea Prophylaxis Market

12.1. China Shigella Diarrhoea Prophylaxis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Shigella Diarrhoea Prophylaxis Market

13.1. India Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Shigella Diarrhoea Prophylaxis Market

14.1. Japan Shigella Diarrhoea Prophylaxis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Shigella Diarrhoea Prophylaxis Market

15.1. Australia Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Shigella Diarrhoea Prophylaxis Market

16.1. Indonesia Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Shigella Diarrhoea Prophylaxis Market

17.1. South Korea Shigella Diarrhoea Prophylaxis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Shigella Diarrhoea Prophylaxis Market

18.1. Taiwan Shigella Diarrhoea Prophylaxis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Shigella Diarrhoea Prophylaxis Market

19.1. South East Asia Shigella Diarrhoea Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Shigella Diarrhoea Prophylaxis Market

20.1. Western Europe Shigella Diarrhoea Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Shigella Diarrhoea Prophylaxis Market

21.1. UK Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Shigella Diarrhoea Prophylaxis Market

22.1. Germany Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Shigella Diarrhoea Prophylaxis Market

23.1. France Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Shigella Diarrhoea Prophylaxis Market

24.1. Italy Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Shigella Diarrhoea Prophylaxis Market

25.1. Spain Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Shigella Diarrhoea Prophylaxis Market

26.1. Eastern Europe Shigella Diarrhoea Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Shigella Diarrhoea Prophylaxis Market

27.1. Russia Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Shigella Diarrhoea Prophylaxis Market

28.1. North America Shigella Diarrhoea Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Shigella Diarrhoea Prophylaxis Market

29.1. USA Shigella Diarrhoea Prophylaxis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Shigella Diarrhoea Prophylaxis Market

30.1. Canada Shigella Diarrhoea Prophylaxis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Shigella Diarrhoea Prophylaxis Market

31.1. South America Shigella Diarrhoea Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Shigella Diarrhoea Prophylaxis Market

32.1. Brazil Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Shigella Diarrhoea Prophylaxis Market

33.1. Middle East Shigella Diarrhoea Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Shigella Diarrhoea Prophylaxis Market

34.1. Africa Shigella Diarrhoea Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Shigella Diarrhoea Prophylaxis Market Regulatory and Investment Landscape

36. Shigella Diarrhoea Prophylaxis Market Competitive Landscape And Company Profiles

36.1. Shigella Diarrhoea Prophylaxis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Shigella Diarrhoea Prophylaxis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Shigella Diarrhoea Prophylaxis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Chongqing Zhifei Biological Products Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Shigella Diarrhoea Prophylaxis Market Other Major And Innovative Companies

Macleods Pharmaceuticals Limited, Alkem Laboratories Limited, Alembic Pharmaceuticals Limited, Vaxcyte Inc., Valneva SE, Sanaria Inc., Intravacc B.V., LimmaTech Biologics AG, Intralytix Inc., Immuron Limited, Institut Pasteur, Hetero Drugs Limited, Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Company Limited

38. Global Shigella Diarrhoea Prophylaxis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Shigella Diarrhoea Prophylaxis Market

40. Shigella Diarrhoea Prophylaxis Market High Potential Countries, Segments and Strategies

40.1 Shigella Diarrhoea Prophylaxis Market In 2030 - Countries Offering Most New Opportunities

40.2 Shigella Diarrhoea Prophylaxis Market In 2030 - Segments Offering Most New Opportunities

40.3 Shigella Diarrhoea Prophylaxis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Shigella Diarrhoea Prophylaxis Market, Overview Of Key Products - Product Examples
  • Table 2: Global Shigella Diarrhoea Prophylaxis Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Shigella Diarrhoea Prophylaxis Market, Supply Chain Analysis
  • Table 4: Global Shigella Diarrhoea Prophylaxis Market, Major Raw Material Providers
  • Table 5: Global Shigella Diarrhoea Prophylaxis Market, Major Resource Providers
  • Table 6: Global Shigella Diarrhoea Prophylaxis Market, Major Manufacturers (Suppliers)
  • Table 7: Global Shigella Diarrhoea Prophylaxis Market, Major Distributors And Channel Partners
  • Table 8: Global Shigella Diarrhoea Prophylaxis Market, Key Technologies & Future Trends
  • Table 9: Global Shigella Diarrhoea Prophylaxis Market, Major Trends
  • Table 10: Global Shigella Diarrhoea Prophylaxis Market, Major End Users
  • Table 11: Global Shigella Diarrhoea Prophylaxis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Shigella Diarrhoea Prophylaxis Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Shigella Diarrhoea Prophylaxis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Shigella Diarrhoea Prophylaxis Market - TAM, US$ Billion, 2025
  • Table 15: Global Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Vaccination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Antibiotic Prophylaxis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Public Health Measures, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Hygiene Education, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Shigella Diarrhoea Prophylaxis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Shigella Diarrhoea Prophylaxis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Shigella Diarrhoea Prophylaxis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Shigella Diarrhoea Prophylaxis Market - Company Scoring Matrix
  • Table 98: Pfizer Inc. Financial Performance
  • Table 99: Merck & Co. Inc. Financial Performance
  • Table 100: GlaxoSmithKline plc Financial Performance
  • Table 101: Viatris Inc. Financial Performance
  • Table 102: Chongqing Zhifei Biological Products Co. Ltd. Financial Performance
  • Table 103: Global Shigella Diarrhoea Prophylaxis Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Shigella Diarrhoea Prophylaxis Market, Competitive Dashboard
  • Table 105: Global Shigella Diarrhoea Prophylaxis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Shigella Diarrhoea Prophylaxis Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Shigella Diarrhoea Prophylaxis Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Table 108: Global, Shigella Diarrhoea Prophylaxis Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Shigella Diarrhoea Prophylaxis Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Shigella Diarrhoea Prophylaxis Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Shigella Diarrhoea Prophylaxis Market, Supply Chain Analysis
  • Figure 4: Global Shigella Diarrhoea Prophylaxis Market, Major Raw Material Providers
  • Figure 5: Global Shigella Diarrhoea Prophylaxis Market, Major Resource Providers
  • Figure 6: Global Shigella Diarrhoea Prophylaxis Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Shigella Diarrhoea Prophylaxis Market, Major Distributors And Channel Partners
  • Figure 8: Global Shigella Diarrhoea Prophylaxis Market, Key Technologies & Future Trends
  • Figure 9: Global Shigella Diarrhoea Prophylaxis Market, Major Trends
  • Figure 10: Global Shigella Diarrhoea Prophylaxis Market, Major End Users
  • Figure 11: Global Shigella Diarrhoea Prophylaxis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Shigella Diarrhoea Prophylaxis Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Shigella Diarrhoea Prophylaxis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Shigella Diarrhoea Prophylaxis Market - TAM, US$ Billion, 2025
  • Figure 15: Global Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Vaccination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Antibiotic Prophylaxis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Public Health Measures, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Shigella Diarrhoea Prophylaxis Market, Sub-Segmentation Of Hygiene Education, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Shigella Diarrhoea Prophylaxis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Shigella Diarrhoea Prophylaxis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Shigella Diarrhoea Prophylaxis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Shigella Diarrhoea Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Shigella Diarrhoea Prophylaxis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Shigella Diarrhoea Prophylaxis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Shigella Diarrhoea Prophylaxis Market - Company Scoring Matrix
  • Figure 98: Pfizer Inc. Financial Performance
  • Figure 99: Merck & Co. Inc. Financial Performance
  • Figure 100: GlaxoSmithKline plc Financial Performance
  • Figure 101: Viatris Inc. Financial Performance
  • Figure 102: Chongqing Zhifei Biological Products Co. Ltd. Financial Performance
  • Figure 103: Global Shigella Diarrhoea Prophylaxis Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Shigella Diarrhoea Prophylaxis Market, Competitive Dashboard
  • Figure 105: Global Shigella Diarrhoea Prophylaxis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Shigella Diarrhoea Prophylaxis Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Shigella Diarrhoea Prophylaxis Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Figure 108: Global, Shigella Diarrhoea Prophylaxis Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Gastrointestinal Devices Market Report 2026 - Global Outlook – By Product Type (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, End...

Gastrointestinal Bleeding Treatment Devices Market Report 2026 - Global Outlook – By Product (Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic A...

Gastrointestinal Endoscopy Market Report 2026 - Global Outlook – By Product (Endoscopes, Camera Heads, Visualization Systems, Biopsy Devices, Capsule Endoscopes, Transmitters And Receivers, Robot-Assisted Endoscopes), By...

Gastrointestinal Stromal Tumor Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Indication (Stomach, Small Intestine, Others Indications), By End-User (H...

Digestive and Intestinal Remedies Market Report 2026 - Global Outlook – By Type (Digestive Medicines, Remedies Against Gastrointestinal Complaints, Natural And Synthetic Agents), By Age Group (Pediatric, Adults), By Dist...

Animal Intestinal Health Market Report 2026 - Global Outlook – By Product (Phytogenics, Probiotics, Immunostimulants, Prebiotics), By Source (Microbial, Plant-Based), By Form (Dry, Liquid), By Livestock (Poultry, Swine, ...

Disposable Intestinal Wash Bags Market Report 2026 - Global Outlook – By Material (Polyvinyl Chloride (PVC), Polyethylene (PE), Polypropylene (PP), Thermoplastic Elastomers (TPE), Other Plastic Materials), By Distributio...

Gastrointestinal Endoscopy Market Report 2026 - Global Outlook – By Product (Endoscopes, Camera Heads, Visualization Systems, Biopsy Devices, Capsule Endoscopes, Transmitters And Receivers, Robot-Assisted Endoscopes), By...

Frequently Asked Questions

The Shigella Diarrhoea Prophylaxis market was valued at $2.12 billion in 2025, increased to $2.29 billion in 2026, and is projected to reach $3.11 billion by 2030.

The global Shigella Diarrhoea Prophylaxis market is expected to grow at a CAGR of 7.9% from 2026 to 2035 to reach $3.11 billion by 2035.

Some Key Players in the Shigella Diarrhoea Prophylaxis market Include, Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Viatris Inc., Chongqing Zhifei Biological Products Co. Ltd., Macleods Pharmaceuticals Limited, Alkem Laboratories Limited, Alembic Pharmaceuticals Limited, Vaxcyte Inc., Valneva SE, Sanaria Inc., Intravacc B.V., LimmaTech Biologics AG, Intralytix Inc., Immuron Limited, Institut Pasteur, Hetero Drugs Limited, Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Company Limited, Janssen Pharmaceuticals (Johnson & Johnson), Sanofi Pasteur, Biological E Limited, Sinovac Biotech Ltd., Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL), Emergent BioSolutions Inc., Codagenix Inc., Indian Immunologicals Limited. .

Major trend in this market includes: Advancements In Vaccine Technology Driving Progress In Shigella Diarrhoea Prevention. For further insights on this market. request a sample here

North America was the largest region in the shigella diarrhoea prophylaxis market in 2025. The regions covered in the shigella diarrhoea prophylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us